|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date28 Feb 2001 |
|
Mechanism5-HT3 receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date29 Dec 1993 |
|
MechanismProton pump inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date31 Dec 1988 |
100 Clinical Results associated with Taiyo Pharma Co., Ltd.
0 Patents (Medical) associated with Taiyo Pharma Co., Ltd.
100 Deals associated with Taiyo Pharma Co., Ltd.
100 Translational Medicine associated with Taiyo Pharma Co., Ltd.